Molecule News and Research

RSS
Separating the good from the bad

Separating the good from the bad

Chemists synthesize natural alkaloid that could have anti-cancer properties

Chemists synthesize natural alkaloid that could have anti-cancer properties

Scientists harness nanoparticles to track cancer-cell changes

Scientists harness nanoparticles to track cancer-cell changes

Next generation ultra-thin materials only one molecule thick

Next generation ultra-thin materials only one molecule thick

Molecule Thymosin beta-4 prompts damaged heart cells to repair themselves after a heart attack

Molecule Thymosin beta-4 prompts damaged heart cells to repair themselves after a heart attack

Enhancing the effects of imatinib mesylate used to treat chronic myeloid leukemia

Enhancing the effects of imatinib mesylate used to treat chronic myeloid leukemia

New small molecule approach to Alzheimer's disease treatment

New small molecule approach to Alzheimer's disease treatment

Synthetic green-glowing genes show how 'silent' mutations influence protein production

Synthetic green-glowing genes show how 'silent' mutations influence protein production

New therapy for metastatic prostate cancer shows promise

New therapy for metastatic prostate cancer shows promise

Thymosin beta-4 protein prompts damaged heart cells to repair themselves after a heart attack

Thymosin beta-4 protein prompts damaged heart cells to repair themselves after a heart attack

Discovery of key decision-point at which cells with broken DNA repair themselves or die

Discovery of key decision-point at which cells with broken DNA repair themselves or die

Researchers explain process by which cells 'hide' potentially dangerous DNA segments

Researchers explain process by which cells 'hide' potentially dangerous DNA segments

Researchers reveal how immune cells can be harnessed to target melanoma

Researchers reveal how immune cells can be harnessed to target melanoma

For cancer cells, genetics alone is poor indicator for drug response

For cancer cells, genetics alone is poor indicator for drug response

Serentis begins trial with first-in-class SRD441 for eczema

Serentis begins trial with first-in-class SRD441 for eczema

New common pathway in neurodegenerative disease is a possible door to a point of no return

New common pathway in neurodegenerative disease is a possible door to a point of no return

Experimental drug lowers PSA levels

Experimental drug lowers PSA levels

New therapy for metastatic prostate cancer shows promise

New therapy for metastatic prostate cancer shows promise

Transplantation immunity breakthrough

Transplantation immunity breakthrough

New nanostructured biosensors

New nanostructured biosensors

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.